tiprankstipranks
Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
Holding ALDX?
Track your performance easily

Aldeyra Therapeutics (ALDX) Ownership - Who Owns Aldeyra Therapeutics?

1,535 Followers

Aldeyra Therapeutics (ALDX) Ownership Overview

19.01%11.31%34.14%10.08%25.46%
19.01% Insiders
34.14% Other Institutional Investors
10.08% ETFs
25.46% Public Companies and
Individual Investors
The ownership structure of Aldeyra Therapeutics (ALDX) stock is a mix of institutional, retail, and individual investors. Approximately 55.53% of the company’s stock is owned by Institutional Investors, 19.01% is owned by Insiders, and 25.46% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 21, 2024
xxxxxxxxxxxxx
$10447
Aug 14, 2024
xxxxxxxxxxxxx
$75874
Apr 08, 2024
xxxxxxxxxxxxx
$833867
Apr 03, 2024
xxxxxxxxxxxxx
$1934505

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$2695000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,275,851Insider15.58%44,616,843
9,275,851Institution15.58%44,616,843
2,879,606Institution4.84%13,850,905
2,493,755Institution4.19%11,994,962
2,043,572Institution3.43%9,829,581
1,471,298Insider2.47%7,076,943
680,004Institution1.14%3,270,819
652,911Institution1.10%3,140,502
552,478Institution0.93%2,657,419
530,393Institution0.89%2,551,190

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,493,755Institution4.19%11,994,962
680,004Institution1.14%3,270,819
552,478Institution0.93%2,657,419
530,393Institution0.89%2,551,190
495,144Institution0.83%2,381,643
310,125Institution0.52%1,491,701
265,151Institution0.45%1,275,376
239,261Institution0.40%1,150,845
206,748Institution0.35%994,458
166,232Institution0.28%799,576

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,758,714Institution2.95%9,250,836
1,366,414Institution2.29%6,572,451
697,567Institution1.17%3,669,202
641,855Institution1.08%3,087,323
420,831Institution0.71%2,024,197
227,339Institution0.38%1,195,803
146,236Institution0.25%769,201
120,686Institution0.20%574,465
113,834Institution0.19%547,542
88,736Institution0.15%438,356

FAQ

Who Owns Aldeyra Therapeutics (ALDX)?
According to the latest TipRanks data, approximately 34.14% of the company's stock is held by institutional investors, 19.01% is held by insiders, and 25.46% is held by retail investors.
    What percentage of Aldeyra Therapeutics (ALDX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 34.14% of Aldeyra Therapeutics (ALDX) stock is held by institutional investors.
      What percentage of Aldeyra Therapeutics (ALDX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 25.46% of Aldeyra Therapeutics (ALDX) stock is held by retail investors.
        Who owns the most shares of Aldeyra Therapeutics (ALDX)?
        Perceptive Advisors Llc owns the most shares of Aldeyra Therapeutics (ALDX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis